Advertisement
FOCL vs MCK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCL is a Hold and MCK is a StrongBuy.
FOCL in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 06, 2026
FOCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 44 cases where FOCL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FOCL's RSI Oscillator exited the oversold zone, 29 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +4.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where FOCL advanced for three days, in 185 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FOCL as a result. In 74 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for FOCL turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 32 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
FOCL moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for FOCL moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for FOCL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-48.608) is normal, around the industry mean (14.423). P/E Ratio (-3.192) is within average values for comparable stocks, (11.188). FOCL's Projected Growth (PEG Ratio) (8.100) is very high in comparison to the industry average of (2.016). Dividend Yield (0.000) settles around the average of (0.134) among similar stocks. P/S Ratio (1.919) is also within normal values, averaging (4.260).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
Aroon Indicator for MCK shows an upward move is likely
MCK's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 355 similar instances where the Aroon Indicator showed a similar pattern. In 260 of the 355 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on MCK as a result. In 54 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MCK just turned positive on November 04, 2026. Looking at past instances where MCK's MACD turned positive, the stock continued to rise in 34 of 52 cases over the following month. The odds of a continued upward trend are 65%.
Following a +7.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in 254 of 382 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
MCK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-29.171) is normal, around the industry mean (14.423). MCK has a moderately high P/E Ratio (28.334) as compared to the industry average of (11.188). Projected Growth (PEG Ratio) (1.616) is also within normal values, averaging (2.016). Dividend Yield (0.004) settles around the average of (0.134) among similar stocks. P/S Ratio (0.265) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
FOCL | MCK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 39 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 6 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 60 | 6 | |
P/E GROWTH RATING 1..100 | 12 | 37 | |
SEASONALITY SCORE 1..100 | n/a | 49 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCK's Valuation (13) in the Medical Distributors industry is somewhat better than the same rating for FOCL (60) in the Biotechnology industry. This means that MCK’s stock grew somewhat faster than FOCL’s over the last 12 months.
MCK's Profit vs Risk Rating (6) in the Medical Distributors industry is significantly better than the same rating for FOCL (100) in the Biotechnology industry. This means that MCK’s stock grew significantly faster than FOCL’s over the last 12 months.
MCK's SMR Rating (100) in the Medical Distributors industry is in the same range as FOCL (100) in the Biotechnology industry. This means that MCK’s stock grew similarly to FOCL’s over the last 12 months.
MCK's Price Growth Rating (6) in the Medical Distributors industry is somewhat better than the same rating for FOCL (60) in the Biotechnology industry. This means that MCK’s stock grew somewhat faster than FOCL’s over the last 12 months.
FOCL's P/E Growth Rating (12) in the Biotechnology industry is in the same range as MCK (37) in the Medical Distributors industry. This means that FOCL’s stock grew similarly to MCK’s over the last 12 months.
| FOCL | MCK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 1 day ago 50% |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 41% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 57% |
| MACD ODDS (%) | 1 day ago 80% | 1 day ago 65% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 70% |
| Advances ODDS (%) | 10 days ago 76% | 7 days ago 66% |
| Declines ODDS (%) | 6 days ago 84% | 3 days ago 43% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 46% |
| Aroon ODDS (%) | 1 day ago 88% | 1 day ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FOCL’s FA Score shows that 1 FA rating(s) are green while MCK’s FA Score has 3 green FA rating(s).
- FOCL’s FA Score: 1 green, 4 red.
- MCK’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FOCL’s TA Score shows that 4 TA indicator(s) are bullish while MCK’s TA Score has 4 bullish TA indicator(s).
- FOCL’s TA Score: 4 bullish, 6 bearish.
- MCK’s TA Score: 4 bullish, 4 bearish.
Price Growth
FOCL (@Medical Distributors) experienced а -14.84% price change this week, while MCK (@Medical Distributors) price change was +8.30% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -12.70%. For the same industry, the average monthly price growth was -15.74%, and the average quarterly price growth was -20.34%.
Reported Earning Dates
MCK is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Medical Distributors (-12.70% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
FOCL and
Correlation & Price change
A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.
| Ticker / NAME | Correlation To FOCL | 1D Price Change % | ||
|---|---|---|---|---|
| FOCL | 100% | +0.86% | ||
| AORT - FOCL | 29% Poorly correlated | -1.81% | ||
| UFPT - FOCL | 20% Poorly correlated | +0.00% | ||
| SENS - FOCL | 20% Poorly correlated | +3.89% | ||
| STXS - FOCL | 16% Poorly correlated | -12.62% | ||
| HBIO - FOCL | 11% Poorly correlated | +4.54% | ||
More | ||||
MCK and
Correlation & Price change
A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.
| Ticker / NAME | Correlation To MCK | 1D Price Change % | ||
|---|---|---|---|---|
| MCK | 100% | -0.26% | ||
| COR - MCK | 70% Closely correlated | +0.34% | ||
| CAH - MCK | 66% Closely correlated | +0.24% | ||
| HKPD - MCK | 10% Poorly correlated | +1.91% | ||
| FOCL - MCK | 9% Poorly correlated | +0.86% | ||
| AHG - MCK | 7% Poorly correlated | +10.40% | ||
More | ||||